Maloney, S.; Itchins, M.; Arena, J.; Sahni, S.; Howell, V.M.; Hayes, S.A.; Gill, A.J.; Clarke, S.J.; Samra, J.; Mittal, A.;
et al. Optimal Upfront Treatment in Surgically Resectable Pancreatic Cancer Candidates: A High-Volume Center Retrospective Analysis. J. Clin. Med. 2021, 10, 2700.
https://doi.org/10.3390/jcm10122700
AMA Style
Maloney S, Itchins M, Arena J, Sahni S, Howell VM, Hayes SA, Gill AJ, Clarke SJ, Samra J, Mittal A,
et al. Optimal Upfront Treatment in Surgically Resectable Pancreatic Cancer Candidates: A High-Volume Center Retrospective Analysis. Journal of Clinical Medicine. 2021; 10(12):2700.
https://doi.org/10.3390/jcm10122700
Chicago/Turabian Style
Maloney, Sarah, Malinda Itchins, Jennifer Arena, Sumit Sahni, Viive M. Howell, Sarah A. Hayes, Anthony J. Gill, Stephen J. Clarke, Jaswinder Samra, Anubhav Mittal,
and et al. 2021. "Optimal Upfront Treatment in Surgically Resectable Pancreatic Cancer Candidates: A High-Volume Center Retrospective Analysis" Journal of Clinical Medicine 10, no. 12: 2700.
https://doi.org/10.3390/jcm10122700
APA Style
Maloney, S., Itchins, M., Arena, J., Sahni, S., Howell, V. M., Hayes, S. A., Gill, A. J., Clarke, S. J., Samra, J., Mittal, A., & Pavlakis, N.
(2021). Optimal Upfront Treatment in Surgically Resectable Pancreatic Cancer Candidates: A High-Volume Center Retrospective Analysis. Journal of Clinical Medicine, 10(12), 2700.
https://doi.org/10.3390/jcm10122700